CVE-2022-46355

Description

A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions < V3.2.7). The affected products are vulnerable to an "Exposure of Sensitive Information to an Unauthorized Actor" vulnerability by leaking sensitive data in the HTTP Referer.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.21%
Vendor Advisory siemens.com
Affected: Siemens SCALANCE X204RNA (HSR)
Affected: Siemens SCALANCE X204RNA (PRP)
Affected: Siemens SCALANCE X204RNA EEC (HSR)
Affected: Siemens SCALANCE X204RNA EEC (PRP)
Affected: Siemens SCALANCE X204RNA EEC (PRP/HSR)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-46355?
CVE-2022-46355 has been scored as a high severity vulnerability.
How to fix CVE-2022-46355?
To fix CVE-2022-46355, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-46355 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-46355 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-46355?
CVE-2022-46355 affects Siemens SCALANCE X204RNA (HSR), Siemens SCALANCE X204RNA (PRP), Siemens SCALANCE X204RNA EEC (HSR), Siemens SCALANCE X204RNA EEC (PRP), Siemens SCALANCE X204RNA EEC (PRP/HSR).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.